BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    PRECISION XTRA

    MDR report key: 2013770 · Received March 10, 2011

    Report

    Report Number
    2954323-2011-02149
    Event Type
    Malfunction
    Date Received
    March 10, 2011
    Date of Event
    January 14, 2011
    Report Date
    March 10, 2011
    Product Code
    NBW
    Removal / Correction Number
    ADC FA1197-2010
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 1

    RETAIN SAMPLES OF PRECISION TEST STRIP LOTS MANUFACTURED WITH HOT-MELT GLUE BATCHES EXHIBITED LOWER THAN EXPECTED READINGS ON CONTINUOUS STORAGE AFTER NINE MONTHS AT 30 DEGREES CELSIUS DURING ROUTINE STABILITY PERFORMANCE TESTING. THIS STABILITY ISSUE COULD LEAD TO THE GENERATION OF INCORRECTLY DEPRESSED BLOOD GLUCOSE RESULTS AND THESE ERRONEOUS RESULTS MAY BE IN THE "C", "D" OR "E" ZONES OF PARKES ERROR GRID, AND AS SUCH, HAVE THE POTENTIAL TO BE CLINICALLY SIGNIFICANT. THE PRIMARY CAUSE HAS BEEN IDENTIFIED TO BE BATCH TO BATCH GLUE VARIABILITY. THE FDA HAS BEEN INFORMED OF THE FIELD ACTION ((B)(4)). (B)(4).

    Description of Event or Problem · 1

    CUSTOMER REPORTED RECEIVING THE FOLLOWING RESULTS FROM HIS PRECISION XTRA BLOOD GLUCOSE METER, WHICH WERE LOWER THAN HE FELT: 79 MG/DL ((B)(6) 2011), 78 MG/DL ((B)(6) 2011), 79 MG/DL ((B)(6) 2011) AND 88 MG/DL ((B)(6) 2011). HE FURTHER REPORTED THAT ON (B)(6) 2011 HE SUBSEQUENTLY EXPERIENCED WEAKNESS AND BLURRED VISION. NO THIRD-PARTY EMERGENT INTERVENTION WAS REPORTED. CUSTOMER SELF-TREATED BY INGESTING GLUCOSE TABLETS AND EATING FOOD. IT WAS ADDITIONALLY REPORTED THE CUSTOMER HAD BEEN USING TEST STRIPS RELATED TO AN ON-GOING FIELD ACTION FOR ABBOTT'S PRECISION FAMILY TEST STRIPS. THERE WAS NO REPORT OF DEATH, SERIOUS INJURY OR MISTREATMENT ASSOCIATED WITH THESE EVENTS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 PRECISION XTRA BLOOD GLUCOSE MONITORING SYSTEM NBW 45001A641

    Patients

    Seq Age Sex Outcome Treatment
    1